Patented Medicine Prices Review Board Rules of Practice and Procedure, SOR/2012-247
Section 26
Testimony by affidavit
Cite as Patented Medicine Prices Review Board Rules of Practice and Procedure, SOR/2012-247, s. 26 · current to July 24, 2025 · regulation last amended June 30, 2021
Statute Watch
Get an alert when a bill in Parliament would change this section, and every time it moves.
The text
(1) Subject to subsection (2), the testimony before the Board on a motion in an interlocutory matter must be by affidavit.
(2) The Board, before or during the hearing of a motion on an interlocutory matter, may grant leave for
(a) a witness to give testimony orally in relation to any points at issues raised in the motion; and
(b) the cross-examination of any person making an affidavit.
Read the Patented Medicine Prices Review Board Rules of Practice and Procedure on the Justice Laws Website ↗
Made under Patent Act, R.S.C. 1985, c. P-4.
Bills in Parliament that would change this section 0
No bill we hold would amend or repeal this section.